Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases
Observational · No treatment assigned · 1 site · University Hospital, Toulouse
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Chronic Inflammatory Bowel Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 100
- Any sex
Some of the main requirements, copied from the record:
- Confirmed diagnosis of Inflammatory Bowel Disease
- Crohn's disease in clinical remission (defined by a Harvey Bradshaw Index ≤ 5) or ulcerative colitis in clinical remission (defined by a Mayo score < 3 and no subscore > 1) for at least 3 months
- Social Security coverage
There are also 5 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 71 participants are expected to take part.
- Start date: 2026-02-10.
- Main results expected around 2027-08-10 (estimate from the record).
- 1 study site listed (1 marked recruiting) in France.
Main thing being measured
- Effectiveness of therapeutic education intervention on physical activity practice (12 months after the inclusion)
In the researchers’ words
Chronic inflammatory bowel diseases (IBD; including Crohn's disease and ulcerative colitis) significantly impact patients' quality of life. Among non-pharmacological therapies, adapted physical activity (APA) has demonstrated its beneficial impact, particularly on fatigue, anxiety, digestive symptoms, and the overall quality of life of patients with IBD.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Chronic Inflammatory Bowel Disease |
| Lead sponsor | University Hospital, Toulouse |
| Enrollment | 71 (estimated) |
| Start date | 2026-02-10 |
| Primary completion (est.) | 2027-08-10 |
| First posted | 2025-12-26 |
| Last updated | 2026-02-13 |
| Official title | Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases |
| ClinicalTrials.gov ID | NCT07305454 |
Interventions
- Inflammatory Bowek Disk Questionnaires (Diagnostic Test)
Patients will be asked to complete the questionnaires regarding bowel inflammation at enrollment, 6 months later, and 12 months later. - Short-International Physical Activity Questionnaries (Other)
Patients will be asked to complete the physical activity questionnaire 6 months later and 12 months later.
Full eligibility criteria (from the record)
Inclusion Criteria: * Confirmed diagnosis of Inflammatory Bowel Disease * Crohn's disease in clinical remission (defined by a Harvey Bradshaw Index ≤ 5) or ulcerative colitis in clinical remission (defined by a Mayo score < 3 and no subscore > 1) for at least 3 months * Social Security coverage Exclusion Criteria: * Pregnant or breastfeeding woman * Patient under legal guardianship * Cardiovascular or rheumatic conditions contraindicating participation in sports * Neurological conditions with residual deficits contraindicating participation in sports * Refusal or inability to consent to participation
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Service de Gastro-Entérologie, CHU Toulouse, Hôpital Rangueil, 1 avenue Jean Poulhès | Toulouse | France | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.